Develops innovative therapeutics targeting Type 2 Diabetes
Caldan Therapeutics has raised €6.3M across 1 funding round from 2 investors, most recently a Series A round in Nov 2015. Based in Glasgow, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series A |
| €6.3M |
| Epidarex Capital,Scottish Investment Bank - Scottish Enterprise |
| View deal → |
